Cervical Cancer Diagnostic Tests Market Cervical Cancer Diagnostic Tests Market : ToC


Cervical Cancer Diagnostic Tests Market

Cervical Cancer Diagnostic Tests Market (Tests (Pap Smear tests, Colposcopy, HPV Testing, Endocervical Curettage (ECC) and Others (Cone Biopsy and Loop Electrosurgical Excision Procedure (LEEP)) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

  • Rep Id : TMRGL736
  • Published On : Nov 2014
  • No. of Pages : 85
  • Category : Healthcare

 
Chapter 1 Introduction
1.1 Report Description
1.2 Research Methodology
1.3 Market Segmentation
 
Chapter 2 Executive Summary
2.1 Market Snapshot: Global Cervical Cancer Diagnostic Tests Market
2.2 Global Cervical Cancer Diagnostic Tests Market, by Type of Tests, 2013 (USD Million)
2.3 Comparative Analysis: Global Cervical Cancer Diagnostic Tests Market, by Geography, 2013 & 2020 (Value %)
 
Chapter 3 Market Overview
3.1 Introduction
3.2 Market Dynamics
      3.2.1 Market Drivers
              3.2.1.1 Rising prevalence rate of cervical cancer expected to boost market growth
              3.2.1.2 High incidence rate of HPV infections likely to drive the growth of the market
              3.2.1.3 Increasing cervical cancer screening awareness programs assisting in accelerating market growth
              3.2.1.4 Breakthrough products and technologies likely to fuel the growth of the market
      3.2.2 Market Restraints
              3.2.2.1 Lack of appropriate primary healthcare infrastructure to impede the growth of the market
              3.2.2.2 Low awareness hinders the growth of the market
      3.2.3 Market Opportunities
              3.2.3.1 Strengthening distribution network in emerging markets
3.3 Porter’s Five Forces Analysis
      3.3.1 Bargaining Power of Suppliers
      3.3.2 Bargaining Power of Buyers
      3.3.3 Threat of New Entrants
      3.3.4 Threat of Substitutes
      3.3.5 Competitive Rivalry
3.4 Market Attractiveness Analysis: Global Cervical Cancer Diagnostic Tests Market, by Geography
3.5 Heat Map Analysis for Cervical Cancer Diagnostic Tests Market, by Key Market Players
 
Chapter 4 Global Cervical Cancer Diagnostic Tests Market, by Type of Test
4.1 Introduction
      4.1.1 Global Cervical Cancer Diagnostic Tests Market Revenue, by Type of Tests, 2012 – 2020 (USD Million)
4.2 Pap Smear Tests
      4.2.1 Global Pap Smear Tests Market Revenue, 2012 – 2020 (USD Million)
4.3 Colposcopy
      4.3.1 Global Colposcopy Market Revenue, 2012 – 2020 (USD Million)
4.4 HPV Testing
      4.4.1 Global HPV Testing Market Revenue, 2012 – 2020 (USD Million)
4.5 Endocervical Curettage (ECC)
      4.5.1 Global Endocervical Curettage (ECC) Market Revenue, 2012 – 2020 (USD Million)
4.6 Others [Cone biopsy and Loop Electrosurgical Excision Procedure (LEEP)]
      4.6.1 Global Other Cervical Cancer Diagnostic Tests Market Revenue, 2012 – 2020 (USD Million)
 
Chapter 5 Global Cervical Cancer Diagnostics Tests Market, by Geography
5.1 Overview
      5.1.1 Global Cervical Cancer Diagnostic Tests Market Revenue, by Geography, 2012-2020 (USD Million)
5.2 North America
      5.2.1 North America Cervical Cancer Diagnostic Tests Market Revenue, 2012 - 2020 (USD Million)
5.3 Europe
      5.3.1 Europe Cervical Cancer Diagnostic Tests Market Revenue, 2012 - 2020 (USD Million)
5.4 Asia Pacific
      5.4.1 Asia Pacific Cervical Cancer Diagnostic Tests Market Revenue, 2012 - 2020 (USD Million)
5.5 Rest of the World (RoW)
      5.5.1 RoW Cervical Cancer Diagnostic Tests Market Revenue, 2012 - 2020 (USD Million)
 
Chapter 6 Recommendations
6.1 Success Strategies (Key Focus Areas)
      6.1.1 Gain Accreditation to Ensure Qualification to Participate in National Screening Programs across the Regions
      6.1.2 Target Emerging Markets of Asia Pacific and RoW
      6.1.3 Intensify Promotion and Training Programs for Healthcare Professionals
      6.1.4 Emphasis on Research and Development to come up with Innovative Solutions
 
Chapter 7 Company Profiles
7.1 Abbott Laboratories
      7.1.1 Company Overview
      7.1.2 Financial Overview
      7.1.3 Product Portfolio
      7.1.4 Business Strategies
      7.1.5 Recent Developments
7.2 Becton, Dickinson and Company
      7.2.1 Company Overview
      7.2.2 Financial Overview
      7.2.3 Product Portfolio
      7.2.4 Business Strategies
      7.2.5 Recent Developments
7.3 Hologic, Inc.
      7.3.1 Company Overview
      7.3.2 Financial Overview
      7.3.3 Product Portfolio
      7.3.4 Business Strategies
      7.3.5 Recent Developments
7.4 F. Hoffmann-La Roche Ltd.
      7.4.1 Company Overview
      7.4.2 Financial Overview
      7.4.3 Product Portfolio
      7.4.4 Business Strategies
      7.4.5 Recent Developments
7.5 Quest Diagnostics, Inc.
      7.5.1 Company Overview
      7.5.2 Financial Overview
      7.5.3 Product Portfolio
      7.5.4 Business Strategies
      7.5.5 Recent Developments
7.6 QIAGEN N.V.
      7.6.1 Company Overview
      7.6.2 Financial Overview
      7.6.3 Product Portfolio
      7.6.4 Business Strategies
      7.6.5 Recent Developments
7.7 Femasys, Inc.
      7.7.1 Company Overview
      7.7.2 Financial Overview
      7.7.3 Product Portfolio
      7.7.4 Business Strategies
      7.7.5 Recent Developments
7.8 Zilico Ltd.
      7.8.1 Company Overview
      7.8.2 Financial Overview
      7.8.3 Product Portfolio
      7.8.4 Business Strategies
      7.8.5 Recent Developments
7.9 Guided Therapeutics, Inc.
      7.9.1 Company Overview
      7.9.2 Financial Overview
      7.9.3 Product Portfolio
      7.9.4 Business Strategies
      7.9.5 Recent Developments
7.10 OncoHealth Corp.
      7.10.1 Company Overview
      7.10.2 Financial Overview
      7.10.3 Product Portfolio
      7.10.4 Business Strategies

List of Tables
 
TABLE 1 Market Snapshot: Global Cervical Cancer Diagnostic Tests Market
TABLE 2 Global Cervical Cancer Diagnostic Tests Market Revenue, by Type of Tests, 2012 - 2020 (USD Million)
TABLE 3 Global Cervical Cancer Diagnostic Tests Market Revenue, by Geography, 2012 – 2020 (USD Million)

List of Figures
 
FIG. 1 Global Cervical Cancer Diagnostic Tests Market Segmentation
FIG. 1 Global Cervical Cancer Diagnostic Tests Market, by Type of Tests, 2013 (USD Million)
FIG. 2 Comparative Analysis: Global Cervical Cancer Diagnostic Tests Market, by Geography, 2013 & 2020 (Value %)
FIG. 3 Cervical Cancer Diagnostic Tests Market, Drivers and Restraints
FIG. 4 Porter’s Five Forces Analysis: Cervical Cancer Diagnostic Tests Market
FIG. 5 Market Attractiveness Analysis: Global Cervical Cancer Diagnostic Tests Market, by Geography
FIG. 6 Heat Map Analysis of Key Market Players for the Cervical Cancer Diagnostic Tests Market
FIG. 7 Global Pap Smear Tests Market Revenue, 2012 – 2020 (USD Million)
FIG. 8 Global Colposcopy Market Revenue, 2012 – 2020 (USD Million)
FIG. 9 Global HPV Testing Market Revenue, 2012 – 2020 (USD Million)
FIG. 10 Global Endocervical Curettage (ECC) Market Revenue, 2012 – 2020 (USD Million)
FIG. 11 Global Other Cervical Cancer Diagnostic Tests Market Revenue, 2012 – 2020 (USD Million)
FIG. 12 North America Cervical Cancer Diagnostic Tests Market Revenue, 2012 - 2020 (USD Million)
FIG. 13 Europe Cervical Cancer Diagnostic Tests Market Revenue, 2012 - 2020 (USD Million)
FIG. 14 Asia Pacific Cervical Cancer Diagnostic Tests Market Revenue, 2012 - 2020 (USD Million)
FIG. 15 RoW Cervical Cancer Diagnostic Tests Market Revenue, 2012 - 2020 (USD Million)
FIG. 16 Abbott Laboratories: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 17 Becton, Dickinson & Company: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 18 Hologic, Inc.: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 19 F. Hoffmann-La Roche Ltd.: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 20 Quest Diagnostics, Inc.: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 21 QIAGEN N.V.: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 22 Guided Therapeutics, Inc.: Annual Revenue, 2011 – 2013 (USD Million)

.